Clincosm LogoSign in Get a demo

Pancreatic Cancer

Showing NaN - NaN of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in New Orleans, Dallas (XB2001 or Placebo)

Recruiting
  • Pancreatic Cancer
  • XB2001 or Placebo
  • Tucson, Arizona
  • +27 more
Jan 27, 2023

Pancreatic Cancer, Pancreas Cancer, Pancreatic Diseases Trial in Canada, United States (Cefoxitin, Piperacillin-tazobactam)

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Sacramento, California
  • +31 more
Jan 12, 2023

Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Dec 1, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

Completed
  • Non-small Cell Lung Cancer
  • +9 more
  • Little Rock, Arkansas
  • +32 more
Dec 12, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Pancreatic Cancer Trial in Australia, Spain, United States (nal-IRI, 5 fluorouracil, Leucovorin)

Completed
Has Results
  • Pancreatic Cancer
  • Mobile, Alabama
  • +35 more
Oct 7, 2022

Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Gilbert, Arizona
  • +16 more
Sep 13, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Pancreatic Cancer Trial in Baltimore, Dallas (ARQ-761, Gemcitabine, nab-paclitaxel)

Terminated
  • Pancreatic Cancer
  • Baltimore, Maryland
  • +1 more
May 31, 2022

Acute Myeloid Leukemia, MDS, Glioblastoma Multiforme Trial in United States (DSP-7888 Dosing Emulsion)

Completed
  • Acute Myeloid Leukemia
  • +8 more
  • DSP-7888 Dosing Emulsion
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Pancreatic Tumors, Pancreatic Cancer Trial in United States (Bardoxolone methyl, Gemcitabine, Placebo)

Terminated
  • Pancreatic Neoplasms
  • Pancreatic Cancer
  • Bardoxolone methyl
  • +2 more
  • Denver, Colorado
  • +4 more
Feb 4, 2022

Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • TALZENNA capsule
  • Talazoparib soft gel capsule
  • Encinitas, California
  • +31 more
Feb 14, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Pancreatic Cancer, Stereotactic Body Radiation Therapy Trial in United States (Avasopasem (GC4419), Placebo, Stereotactic

Completed
  • Pancreatic Cancer
  • Stereotactic Body Radiation Therapy
  • Avasopasem (GC4419)
  • +2 more
  • Tampa, Florida
  • +5 more
Jan 6, 2022

NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in United States (NBF-006)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Beverly Hills, California
  • +8 more
Dec 21, 2021

HER2 Positive Gastric Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (FATE-NK100,

Completed
  • HER2 Positive Gastric Cancer
  • +10 more
  • San Diego, California
  • +3 more
Nov 18, 2021

Metastatic Pancreatic Cancer, Pancreatic Cancer Trial in Worldwide (IMMU-107, , Gemcitabine)

Terminated
  • Metastatic Pancreatic Cancer
  • Pancreatic Cancer
  • Gilbert, Arizona
  • +64 more
Aug 12, 2021

Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

Completed
Has Results
  • Gastric Adenocarcinoma
  • +15 more
  • Sacituzumab Govitecan-hziy (SG)
  • Aurora, Colorado
  • +11 more
Aug 10, 2021

Pancreatic Cancer Trial in Worldwide (Registry)

Active, not recruiting
  • Pancreatic Cancer
  • Registry
  • Birmingham, Alabama
  • +15 more
Apr 8, 2021

Pancreatic Cancer Trial in Dallas (Warfarin)

Withdrawn
  • Pancreatic Cancer
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Mar 23, 2021